Other OTC - Delayed Quote USD

Elite Pharmaceuticals, Inc. (ELTP)

0.1263 +0.0031 (+2.52%)
At close: April 24 at 3:59 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
47,317.6240
34,155.1140
32,262.1170
25,380.7490
Cost of Revenue
25,637.5120
17,561.0930
17,466.7630
13,513.6110
Gross Profit
21,680.1120
16,594.0210
14,795.3540
11,867.1380
Operating Expense
14,714.0190
12,625.2120
9,724.6440
9,762.6150
Operating Income
6,966.0930
3,968.8090
5,070.7100
2,104.5230
Net Non Operating Interest Income Expense
-678.6130
-1,105.2540
-191.6900
-259.0840
Other Income Expense
-8,673.8240
1,122.3190
1,425.4090
2,299.0750
Pretax Income
-2,386.3440
3,985.8740
6,304.4290
4,144.5140
Tax Provision
-17,939.8540
424.0280
-1,736.4370
-943.9070
Earnings from Equity Interest Net of Tax
946.4070
--
857.3790
943.9070
Net Income Common Stockholders
15,553.5100
3,561.8460
8,898.2450
5,088.4210
Average Dilution Earnings
550.0720
--
-1,425.4090
-1,237.1320
Diluted NI Available to Com Stockholders
14,992.4400
3,561.8460
8,898.2450
3,851.2890
Basic EPS
0.02
0.00
0.01
0.01
Diluted EPS
0.02
0.00
0.01
0.00
Basic Average Shares
1,014,250.1310
1,012,911.3460
1,010,607.7130
942,997.8750
Diluted Average Shares
1,018,185.1200
1,012,911.3460
1,010,607.7130
942,997.8750
Total Operating Income as Reported
6,673.2860
3,676.0020
5,070.7100
2,104.5230
Total Expenses
40,351.5310
30,186.3050
27,191.4070
23,276.2260
Net Income from Continuing & Discontinued Operation
15,553.5100
3,561.8460
8,898.2450
5,088.4210
Normalized Income
18,517.9439
2,558.9223
7,772.1719
3,410.0963
Interest Income
23.3510
7.4530
0.1260
0.5140
Interest Expense
701.9640
1,112.7070
191.8160
259.5980
Net Interest Income
-678.6130
-1,105.2540
-191.6900
-259.0840
EBIT
-1,684.3800
5,098.5810
6,496.2450
4,404.1120
EBITDA
-324.5600
6,443.2640
7,930.9540
5,928.7030
Reconciled Cost of Revenue
25,606.6720
17,479.8620
17,226.9930
13,302.8670
Reconciled Depreciation
1,359.8200
1,344.6830
1,434.7090
1,524.5910
Net Income from Continuing Operation Net Minority Interest
15,553.5100
3,561.8460
8,898.2450
5,088.4210
Total Unusual Items Excluding Goodwill
-3,752.4480
1,122.3190
1,425.4090
2,299.0750
Total Unusual Items
-3,752.4480
1,122.3190
1,425.4090
2,299.0750
Normalized EBITDA
3,427.8880
5,320.9450
6,505.5450
3,629.6280
Tax Rate for Calcs
0.0002
0.0001
0.0002
0.0003
Tax Effect of Unusual Items
-788.0141
119.3953
299.3359
620.7503
3/31/2021 - 2/24/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KGKG Kona Gold Beverage, Inc.
0.0018
+5.88%
 
MEDXF Medexus Pharmaceuticals Inc.
1.3000
+7.00%
 
IGPK Integrated Cannabis Solutions, Inc.
0.0155
+14.81%
 
EBS Emergent BioSolutions Inc.
2.1800
-4.80%
 
GRUSF Grown Rogue International Inc.
0.6520
-1.82%
 
SNOA Sonoma Pharmaceuticals, Inc.
0.1600
+0.63%
 
VRNOF Verano Holdings Corp.
5.20
+7.66%
 
OPTN OptiNose, Inc.
0.9253
-4.38%
 
AYURF Ayurcann Holdings Corp.
0.0229
-6.53%
 
ROMJF Rubicon Organics Inc.
0.2661
-1.17%